Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.

Antimicrobial agents and chemotherapy - 1 Sept 2010

Castanheira Mariana, Watters Amy A, Bell Jan M, Turnidge John D, Jones Ronald N

Abstract excerpt

Among 4,167 Staphylococcus aureus and 790 coagulase-negative Staphylococcus (CoNS; not S. saprophyticus) isolates collected consecutively from North American and Australian hospitals, only 87 (1.7% overall) isolates displayed a fusidic acid (FA; also known as CEM-102) MIC of > or = 2 microg/ml (F...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Australia
Share to Bacterial Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Bacterial

Share to Microbial Sensitivity Tests

Share to Mutation

Share to North America

Share to Staphylococcus

Source

Open in PubMed Open full text

Identifiers

PMID: 20566766
DOI: 10.1128/AAC.01390-09
PMCID: PMC2934946

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20566766-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fusidic acid resistance rates and prevalence of resistance mechanisms among Staphylococcus spp. isolated in North America and Australia, 2007-2008.PMID 20566766Read ↗

Occurrence and molecular characterization of fusidic acid resistance mechanisms among Staphylococcus spp. from European countries (2008).Semantic proximity Read ↗

Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolatesSemantic proximity Read ↗

Fusidic acid resistance in Staphylococcus aureusSemantic proximity Read ↗

High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidisSemantic proximity Read ↗

Fusidic acid resistance determinants in Staphylococcus aureus clinical isolates.Semantic proximity Read ↗

Characterization of global patterns and the genetics of fusidic acid resistance.Semantic proximity Read ↗

Prevalence of fusB in Staphylococcus aureus clinical isolates.Semantic proximity Read ↗

Mechanisms of fusidic acid resistance.Semantic proximity Read ↗

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistance.Semantic proximity Read ↗

Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014.Semantic proximity Read ↗

Distribution of Fusidic Acid Resistance Determinants in Methicillin-Resistant Staphylococcus aureusSemantic proximity Read ↗

Prevalence and molecular characterization of methicillin-resistant Staphylococcus aureus with mupirocin, fusidic acid and/or retapamulin resistanceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.